Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LF111 or Drospirenone Chewable Tablets on BMD in Adolescent and Adult Women
NCT05303636Phase 4Active, not recruiting
- Sponsor
- Insud Pharma
- Start
- Mar 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of drospirenone in pregnancy, sponsored by Insud Pharma. Started Mar 2022; status: active, not recruiting.
02
Drugs
drospirenone
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT05303636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05303636.